DRAP-approved generic medicines in Pakistan must meet the same safety and efficacy standards as their branded equivalents. The main practical difference is cost, generics are significantly cheaper because manufacturers do not carry the research and development costs of the original product, and market competition among multiple generic producers drives prices lower still. The active ingredient, dose, dosage form, and route of administration are the same; what changes is the price and the name on the packaging.
This article covers what bioequivalence actually means in plain terms, how DRAP's registration process applies to generic medicines in Pakistan, when a generic can be safely substituted for a branded product, and what to check before switching. All health content here is supervised by Naiha Saeed, MLT (Medical Laboratory Technologist). Always consult your doctor or pharmacist before switching between a branded and generic version of any medicine, the general guidance in this article does not replace professional advice on your specific situation.
What "Bioequivalent" Actually Means?
Bioequivalence is the regulatory standard that determines whether a generic medicine can be considered interchangeable with its branded equivalent. Bioequivalence generally means the generic drug delivers the same amount of active ingredient to a patient at the same rate and to the same extent as the branded drug. In practical terms: the same medicine reaches your bloodstream in the same quantity and at the same speed, producing the same therapeutic effect.
Because the active ingredient in the generic medication has already been shown in testing of the brand-name medication to be safe and effective, bioequivalence studies only have to show that the generic version produces the same levels of medication in the blood over time. This is why generics do not need to repeat the full clinical trials that the original branded product went through, the safety and efficacy of the active ingredient is already established.
A large population-wide study covering over 9 million patients across six years found that generic medications were at least similar, and in some cases superior, to their branded counterparts regarding mortality and major cardiovascular events for antihypertensive, lipid-lowering, and antidiabetic medicines, three of the most commonly taken chronic-condition drugs in Pakistan.
How DRAP Regulates Generic Medicines in Pakistan?
DRAP applies the same registration framework to generic medicines that it uses for any pharmaceutical product, a generic cannot be sold legally in Pakistan without DRAP registration, and registration requires evidence of bioequivalence. DRAP's Registration Board resolved in July 2024 that the regulatory approval process for generic drug registration will include implementation of bioequivalence studies in adherence to WHO guidelines.
DRAP's guidance on bioequivalence studies is applicable to orally administered generic drug products and provides guidance to industry for in vivo and in vitro requirements to assure interchangeability of the generic product without compromising safety, quality, and efficacy.
This means a generic medicine carrying a DRAP registration number has been assessed for its ability to deliver the same active ingredient in the same way as the branded product it references, it is not simply assumed to be equivalent based on having the same active ingredient listed on the label.
Bonus tip: Before accepting a generic substitution at a pharmacy, check that the generic product has a DRAP registration number on its packaging. A product without a registration number has not been through DRAP's evaluation process, which is a separate concern from the branded vs. generic question entirely.
Direct Comparison: Generic vs Branded Medicine in Pakistan
| Factor | Branded Medicine | DRAP-Registered Generic |
|---|---|---|
| Active ingredient | Original formulation | Same active ingredient, same dose |
| Bioequivalence requirement | N/A (original product) | Required for DRAP registration under WHO guidelines |
| Therapeutic effect | Established through clinical trials | Same, established through bioequivalence testing |
| Price | Higher, includes R&D and marketing costs | Significantly lower, no R&D cost, multiple manufacturers competing |
| Packaging and appearance | Proprietary design | May differ in colour, shape, or packaging, legally permitted |
| DRAP registration number | Present | Present (required for legal sale in Pakistan) |
| Availability in Pakistan | Originator brands showed only 6.8% availability in public sector facilities and 55% in private pharmacies | Generally higher availability across public and private pharmacies |
Why Generic Medicines Are Cheaper, and Why That Does Not Mean Lower Quality?
The cost difference between branded and generic medicine comes from the cost structure of production, not from quality. A branded medicine's price includes the cost of original drug discovery, years of clinical trials, regulatory approval across multiple countries, and marketing. Generic drugs contain the same active ingredients and must work the same way in the body as the brand drug, and have the same strength, dosage form, and route of administration.
Generic manufacturers skip the original discovery and trial costs because those have already been borne by the innovator company, and once a patent expires, multiple manufacturers can produce the same active ingredient, driving prices down further through market competition. Pakistan-specific medicine price research confirms this pattern: medicines listed on Pakistan's National Essential Medicines List were consistently cheaper than non-NEML medicines, with the lowest-priced generics providing meaningful cost reduction compared to originator brands.
For patients managing chronic conditions requiring daily medication, diabetes, hypertension, thyroid conditions, this cost difference compounds over months and years into a substantial reduction in out-of-pocket spending.
Bonus tip: SehatKart lists products by pharmacy on the platform, customers in Sadiqabad can compare whether a listed pharmacy carries the generic or branded version of a specific medicine before ordering, rather than being limited to whatever a single counter happens to stock.
When a Generic Can Be Substituted and When to Check First?
Most DRAP-registered generics can be substituted for their branded equivalent without any change in therapeutic outcome for the majority of patients. However, a small number of medicine categories require more caution around substitution, and these are worth knowing before assuming every switch is straightforward.
Medicines with a narrow therapeutic index, where the difference between a therapeutic dose and a toxic dose is small, require closer attention when switching between branded and generic versions. Examples include certain anticoagulants, antiepileptics, and immunosuppressants. For these specific categories, your doctor or pharmacist should be involved in any switch decision rather than the substitution being made automatically at the pharmacy counter.
For the vast majority of medicines, including most antihypertensives, oral antidiabetics, antibiotics, and pain relief medicines, a DRAP-registered generic is a safe and therapeutically equivalent substitution.
What to Check Before Switching to a Generic Medicine?
Before accepting or ordering a generic substitution:
- Does the generic have a DRAP registration number? Check the packaging. A registered product displays this number; an unregistered product should not be dispensed at a licensed pharmacy.
- Is the active ingredient name and dose the same? The active ingredient (generic name) and dose should be identical to the branded product being substituted.
- Is this medicine in a category that requires careful switching? For anticoagulants, antiepileptics, or other narrow therapeutic index medicines, ask your doctor or pharmacist before switching rather than making the change independently.
- Has your doctor already specified "branded only" on the prescription? Some prescriptions specify no substitution, this should be followed unless the prescribing doctor confirms otherwise.
Common Questions
Are generic medicines in Pakistan as safe as branded ones?
Yes, provided they carry a DRAP registration number. DRAP requires bioequivalence evidence to assure interchangeability of the generic product without compromising safety, quality and efficacy. An unregistered product, branded or generic, carries a different and separate risk.
Can a pharmacist substitute a generic for the branded medicine on my prescription?
In Pakistan, pharmacists can suggest a generic equivalent, but the substitution should be discussed with you and, where relevant, confirmed against your doctor's instructions. If your prescription specifies a specific brand, clarify with your doctor before switching.
Why does my generic medicine look different from the branded version I normally take?
The FDA generally allows minor differences in appearance between generic and brand drugs, such as colour. These appearance differences are legally required to distinguish the products from each other, they do not indicate a difference in the active ingredient or how the medicine works. DRAP follows the same principle.
Can I order generic medicines for home delivery in Pakistan?
Yes, pharmacies listed on platforms like SehatKart carry both branded and generic versions of many commonly prescribed medicines. Whether a specific generic is available depends on individual pharmacy stock, which is visible before ordering.
How do I know if the generic medicine delivered is the right one?
Check the active ingredient name and dose on the packaging against your prescription. If the generic name (e.g. "amlodipine 5mg") matches what was prescribed, the product is the correct active ingredient regardless of what brand name appears on the box. If anything looks unclear, ask your pharmacist before using it.
My doctor always prescribes a branded medicine, can I ask for the generic instead?
Yes, you can discuss with your doctor whether a DRAP-registered generic equivalent is appropriate for your specific situation. Some doctors prescribe branded medicines out of familiarity or for specific reasons related to a patient's history. The conversation is worth having, particularly for long-term daily medication where cost is a factor.
Do generic medicines take longer to work than branded ones?
No. Bioequivalence testing specifically confirms that the generic delivers the active ingredient at the same rate and to the same extent as the branded product. A different onset time would indicate the products are not bioequivalent, which would prevent DRAP registration.
What should I do if I feel the generic medicine is not working the same as the branded version I was on before?
Speak to your pharmacist or doctor rather than discontinuing medication. Individual variation in response to medicines is real, and your healthcare provider can assess whether the change is related to the medicine switch or to other factors. Do not stop a prescribed medicine without medical guidance.
Is the National Essential Medicines List relevant to which generics are available?
Yes, medicines listed on Pakistan's National Essential Medicine List are more consistently available and priced lower than non-NEML products. If cost or availability is a concern for a specific medicine, checking whether it appears on the NEML is a useful starting point.
Conclusion
DRAP-registered generic medicines in Pakistan go through a bioequivalence assessment that confirms they deliver the same active ingredient in the same way as their branded counterparts. The cost difference is real and meaningful, particularly for patients managing chronic conditions over months and years, but it reflects production economics rather than quality.
For the vast majority of commonly prescribed medicines, a DRAP-registered generic is a safe and cost-effective alternative. For a small set of narrow therapeutic index medicines, a pharmacist or doctor should be part of any switch decision. The key check in every case is the DRAP registration number on the packaging, registered and unregistered are the distinction that matters most, not branded versus generic.
Order Medicine in Sadiqabad
Browse pharmacies and check generic availability before ordering at sehatkart.co. SehatKart connects patients in Sadiqabad to DRAP-verified local pharmacies for home delivery, with payment via JazzCash, EasyPaisa, or Cash on Delivery. Delivery fee: Rs. 130. Reach the team at support@sehatkart.co or WhatsApp +923006707390 for questions about specific medicines.
Sources:
- DRAP Bioequivalence and Bioavailability Guidance, dra.gov.pk
- DRAP Draft Bio-availability & Bio-equivalence Guidelines, dra.gov.pk
- Generic Drugs: Questions & Answers, FDA
- Bioequivalence and Interchangeability of Generic Medications, Merck Manual
- Comparative effectiveness of branded vs. generic antihypertensive, lipid-lowering and hypoglycemic substances, PMC
- Pakistan medicine price deregulation impact on oral anti-diabetic medicines, PMC
- Evaluation of prices, availability and affordability of essential medicines in Lahore, PLOS ONE
